Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001595585-19-000013
Filing Date
2019-01-30
Accepted
2019-01-30 20:14:49
Documents
3
Period of Report
2019-01-28

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_154889727043710.html 3  
1 FORM 3 wf-form3_154889727043710.xml 3 1716
2 POWER OF ATTORNEY (CANTRELL) poasusannahcantrell.htm EX-24 4806
3 POWER OF ATTORNEY (CANTRELL) poasusannahcantrell001.jpg GRAPHIC 210501
  Complete submission text file 0001595585-19-000013.txt   297982
Mailing Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address 7000 SHORELINE COURT, SUITE 201 SOUTH SAN FRANCISCO CA 94080 415-429-7800
Tricida, Inc. (Issuer) CIK: 0001595585 (see all company filings)

EIN.: 463372526 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 7000 SHORELINE COURT SUITE 201 SOUTH SAN FRANCISCO CA 94080
Business Address
Cantrell Susannah (Reporting) CIK: 0001765984 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38558 | Film No.: 19553415